姓名：丁惠国 性别：男 职称：主任医师、教授 招生院所：北京佑安医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：内科学（消化系病）(博) 内科学（消化系病）(硕) 研究方向名称：肝脏病学 电子信箱：dinghuiguo@medmail.com.cn


社会任职
1. Hepatoma Research 编委
2. 北京中西医学会肝病专业委员会常务委员
3. 北京医学会肝病专业委员会常务委员兼秘书
4. 北京医学会消化内镜专业委员会常委
5. 中国医科大学学报特约审稿
6. 临床肝胆病杂志编委
7. 中华消化病学会肝胆病学组委员
8. 药物不良反应杂志编委
9. 中国研究型医院学会肝病专业委员会副主任
10. 中华预防医学会肝胆胰疾病预防与控制专业委员会委员
11. 北京医师协会感染科专科医师分会常务理事
12. 中国医师协会消化分会肝病专业委员会副主任
13. 中华医学会肝病学分会委员
14. 中华肝脏病杂志编委
个人简历
1. 198309-198806:重庆医科大学 学习
2. 198807-199009:北京佑安医院 住院医师
3. 199009-199306:首都医科大学附属北京友谊医院 研究生/住院医师
4. 199307-199908:北京佑安医院 住院医师/主治医师
5. 199909-200204:首都医科大学附属北京友谊医院 博士/副主任医师
6. 200206-200211:香港大学医学院玛丽医院 进修
7. 200212-:首都医科大学附属北京佑安医院 主任医师/教授
8. 201103-201104:英国牛津大学 短期访问
重要学术论文
1. Lv XY, Ding HG, Zheng JF, Fan CL, Li L.Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study.. World J Gastroenterol.. 2020,26（2）:199-218.SCI
2. Xu XY, Ding HG, Li WG, Jia JD, Wei L, Duan ZP, Liu YL, Ling-Hu EQ, Zhuang H, Hepatology CSO, Association CM..Chinese guidelines on management of hepatic encephalopathy in cirrhosis.. World J Gastroenterol. 2019,25（36）:5403-5422.SCI
3. Nevens F, Bittencourt PL, Coenraad MJ, Ding H, Hou MC, Laterre PF, Mendizabal M, Ortiz-Olvera NX, Vorobioff JD, Zhang W, Angeli P.Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis. Dig Dis Sci. . 2019,1: doi: 10.1007/s10620-018-5448-y.SCI
4. Chinese Society of Hepatology, Chinese Medical Association, Xu X, Duan Z, Ding H*, Li W, Jia J, Wei L, Linghu E, Zhuang H.Chinese guidelines on the management of ascites and its related complications in cirrhosis.. Hepatol Int. 2019,13（1）:1-21.SCI
5. 范春蕾，李磊，李鹏，王贞彪，丁惠国*.虚拟消化内镜模拟系统在传染病专科医院胃镜技能教学中的应用. 中华医学教育探索杂志. 2019,18（1）:85-88.核心期刊
6. Junfu Zheng, Yuening Zhang, Peng Li, Shibin Zhang,Yue Li, Lei Li, Huiguo Ding(*).The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study. BMC Gastroenterology. 2019,19:1-9.SCI
7. Sungjin Ko, Jacquelyn O. Russell, Jianmin Tian, Ce Gao, Makoto Kobayashi, Rilu Feng,Xiaodong Yuan, Chen Shao,Huiguo Ding,Minakshi Poddar, Sucha Singh,Joseph Locker,Hong-Lei Weng,Satdarshan P. Monga,Donghun Shin..Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8. Gastroenterology. 2019,156:187-202.SCI
8. Shuzhen Wang,Xin Zhang, Tao Han, Wen Xie, Yonggang Li, Hong Ma, Roman Liebe,Honglei Weng,Hui-Guo Ding(*).Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia. BMC Gastroenterology. 2018,18(1):137-143.SCI
9. Wang S, Cui S, Zhao W, Qian Z, Liu H, Chen Y, Lv F, Ding HG(*).Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.. Cancer Biomark. 2018,22(4):631-640.SCI
10. 王文娟，宋琪，丁惠国*.肝硬化急性肾损伤的临床特点与危险因素. 中华内科杂志. 2018,57(12):912-917.核心期刊
11. Wang Shanshan, Zhu Mingyue, Wang Qiaoyun, Hou Yuli,Li Lei, Weng Honglei,Zhao Yan, Chen Dexi, Ding Huiguo(*), Guo Junli,Li Mengsen(*).Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.. Cell Death Dis. 2018,9(10):1020-1027.SCI
12. Fuquan Liu,Zhenyuan Ning, Yanna Liu, Dengxiang Liu,Jie Tian,Hongwu Luo,Weimin An,Yifei Huang,Jialiang Zou,Chuan Liu,Changchun Liu,Lei Wang,Zaiyi Liu,Ruizhao Qi,Changzeng Zuo,Qingge Zhang,Jitao Wang,Dawei Zhao,Yongli Duan,Baogang Peng,Xingshun Qi,Zhiwei Li,Huiguo Ding(*), Yu Zhang(*), Xiaolong Qi(*).Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EbioMedicine. 2018,36:151-158.SCI
13. Shichang Cui, Zhiling Qian, Yuehan Chen, Lei Li, Peng Li and Huiguo Ding*.Screening of up and down regulation of circRNAs in HBV-related hepatocellular carcinoma patients by microarray. Oncology Letter. 2018,15(1):423-432.SCI
14. Hou F, Liu R, Liu X, Cui L, Yu X, Wen Y, Ding H*, Yin C.Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis. Int J Mol Med. . 2018,41(3):1315-1322..SCI
15. 李越，李鹏，张月宁，丁惠国*.肝静脉压力梯度指导的肝硬化门脉高压症诊治策略：梦想？现实？. 中华肝脏病杂志. 2018,26（4）:254-258.核心期刊
16. 丁惠国,张世斌,李磊,李鹏,张月宁,王贞彪..肝硬化食管胃底静脉曲张的内镜诊断治疗—从指南到临床实践. 临床肝胆病杂志. 2017,33(3):: 454-457..核心期刊
17. Chen Y, Fan C, Chen Y, Liu H, Wang S, Dong P, Li L and Ding H*.Effect of hepatic steatosis on the progression of chronic hepatitis B：A prospective cohort and in vitro study. Oncotarget . 2017,8:58601-58610..SCI
18. 王征,丁惠国*,陈玉涵,李磊,范春蕾,董培玲.中国北方地区肝硬化病因及并发症的变迁. 首都医科大学学报. 2017,38(4):604-608.核心期刊
19. 王淑珍,丁惠国*..肝硬化顽固性腹水新的治疗模式及理念. 中华肝脏病杂志. 2017,25（4）:249-254..核心期刊
20. Wei HT, Yu XT, Xue XW, Liu H, Wang WL. Li YY, Wang XJ,Ding HG*.Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients. Oncology Letter. 2017,14(3):2749-2756.SCI
21. Stefan Munker, Yong-Le Wu, Hui-Guo Ding, Roman Liebe, Hong-Lei Weng.Can a fibrotic liver afford epithelial-mesenchymaltransition?. World J Gastroenterol . 2017,23(26):4661-4668..SCI
22. Hongtao Wei, Hui Liu,Yuhan Chen,Xiaowei Xue, Honglei Weng, and Huiguo Ding*.The histopathological features and CT/MRI imaging performances in hepatic angiomyolipoma patients. Ann Hepatol. 2017,16(5):759-764..SCI
23. HanYing(#), ZengAjuan, Liao Huiyu, Liu Yanmin, Chen Yuhan, Ding Huiguo(*).The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis . International Immunopharmacology. 2017,42:168-175.SCI
24. Jia J, Hou J, Ding H, Chen G, Xie Q, Wang Y, Zeng M, Zhao J, Wang T, Hu X, Schuppan D.Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol. 2015,30(4):756-762.SCI
25. Zhao-Hua Cai, Chun-Lei Fan, Jun-Fu Zheng, Xin Zhang, Wen-Min Zhao, Bing Li, Lei Li,Pei-Ling Dong, Hui-Guo Ding*.Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis.. BMC Infectious Diseases. 2015,15:55:1-6.SCI
26. 李鹏，丁惠国*.肝癌危险因素及早期诊断与筛查. 中国实用内科杂志. 2015,3:1-5.核心期刊
27. Wu Y, Liu H, Weng H, Zhang X, Li P, Fan CL, Li B, Dong PL, Li L, Dooley S, Ding HG*.Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway. Int J Oncol. 2015,46(3):1275-85.SCI
28. 李 鹏, 陈玉涵, 张世斌, 丁惠国*..乙型肝炎肝硬化患者不同肝癌筛查方案的比较及对预后影响.. 世界华人消化杂志. 2015,23(20):3298-3303..核心期刊
29. 韩莹,丁惠国*.乙肝肝硬化抗病毒治疗的过去、现在和未来. 实用肝脏病杂志. 2015,5:1-3.核心期刊
30. 吴燕京,张月宁,李鹏,赵大伟,张世斌,翟云,董培玲,李宏军,丁惠国*. 19例肝脏局灶性结节性增生的临床和影像学特点. 中华消化病杂志. 2015,2:95-98.核心期刊
31. Peng Li, Huiguo Ding*.Stratified screening of HCC in high rosk popolations. Radiolgy of Infectious Disease. 2015,07:1-4.
32. 曾阿娟 ，范春蕾， 李磊， 张鑫， 赵文敏， 郑俊福 ，王征 ，董培玲 ，丁惠国*.核苷（酸）类抗病毒药物对失代偿期乙型肝炎肝硬化患者肾功能的影响研究. . 实用肝脏病杂志. 2015,5:34-37.核心期刊
33. 李鹏,翟云,张世斌,李磊,丁惠国*. .抗病毒治疗对HBV相关终末期肝细胞癌患者生存质量及预后的影响. 临床肝胆病杂志. 2015,5:721-724.核心期刊
34. 张鑫，丁惠国*.获得性肝脑变性:一种少见的肝病相关神经系统病变. 中华肝脏病杂志. 2015,23(4):314-316.核心期刊
35. 陈宁,王珊珊,陈玉涵,殷继明, 陈德喜,丁惠国1*.外源性硫化氢对肝癌细胞系HepG2自噬的影响. 首都医科大学学报. 2015,36:116-120.核心期刊
36. 曾阿娟,丁惠国#，刘玉兰.核苷(酸)类似物初始治疗对失代偿期乙肝肝硬化病毒学及并发症的影响：一项多中心、前瞻性观察性研究. 中华消化病杂志. 2015,2:80-85.核心期刊
37. Xin Zhang, Shu-Zhen Wang, Jun-Fu Zheng, Wen-Min Zhao, Peng Li, Chun-Lei Fan, Bing Li, Pei-Ling Dong，Huiguo Ding*.Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients. . World J Gastroenterol,. 2014,20(32):11400-11405.SCI
38. 杨梦媛,李冰,丁惠国*.肝脏疾病对内分泌激素的影响. 中华肝脏病杂志. 2014,22(2):196-200.核心期刊
39. Rui Zhang, DongxuZhao, Hui-GuoDing , Yan-XiangHuang , Hai-ZhengZhong,.Sensitivesingle-color fluorescence “off–on” switch system for dsDNA detection based on quantumdots-ruthenium assembling dyads. Biosensors and Bioelectronics,. 2014,56:51–57.SCI
40. 窦爱华,郑俊福,刘晖,李磊,李冰,董培玲,丁惠国*.. 肝硬化合并2型糖尿病发生原发性肝癌的风险研究.. 北京医学. 2013,35（6）:412-415.核心期刊
41. 武永乐,李冰,刘晖,李鹏,吕福东,丁惠国*.GPC3对AFP阴性乙型肝炎病毒相关肝细胞癌的诊断价值. 北京医学. 2013,35（6）:416-419.核心期刊
42. Duan BW, Lu SC, Wang ML, Liu JN, Chi P, Lai W, Wu JS, Guo QL, Lin DD, Liu Y, Zeng DB, Li CY, Meng QH, Ding HG, Chen XY, Liao HY, Ma LQ, Chen Y, Zhang J, Xiang HP, Duan ZP, Li N.Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.. J Surg Res. 2013,183（2）:936-943.SCI
43. Lei Li, Wei Liu, Yu-Han Chen, Chun-Lei Fan, Pei-Ling Dong, Fei-Li Wei, Bing Li,De-Xi Chen, Hui-Guo Ding*..Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study. . World Journal of Gastroenterology.World J Gastroenterol . 2013,19(45):8373-8381.
44. Li B, Liu H, Shang HW, Li P, Li N, *Ding HG.Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients. African Health Sciences. 2013,13(3):703 - 709.SCI
45. 丁惠国.重视原发性肝癌的规范化筛查与监测. 北京医学. 2013,35（6）:409-411.核心期刊
46. Dong PL, Zhang X, Zhao WM, Ding HG*.HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report. . J Infect Chemother. 2013,19（6）:1188-1192.SCI
47. 范春蕾,丁惠国*.非选择性β受体阻滞剂预防肝硬化食管胃静脉曲张出血研究进展. 中华医学杂志. 2013,93（6):474-476.核心期刊
48. 曾阿娟,范春蕾,丁惠国*.非选择性ß受体阻断剂与肝硬化门脉高压症. 实用肝脏病杂志. 2013,16(3):2012-204.核心期刊
49. Zhang Lijie, Liu Hui, Sun Lin, Li Ning, Ding Huiguo*, Zheng Jie.Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Acta histochemica. 2012,114(6):547-552.SCI
50. 韩莹,刘燕敏,廖慧钰,胡中杰,范春蕾,李磊,丁惠国*.无创诊断指标对乙型肝炎肝硬化患者伴食管胃静脉曲张风险的评估. 中华肝脏病杂志. 2012,20（2):141-143.核心期刊
51. Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, Li F, Protzer U, Ding H*, Zeng C.Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. BMC Microbiol. 2012,12(1):307-313.SCI
52. Peng Li, Shan-Shan Wang, Hui Liu, Ning Li, Michael A McNutt, Gang Li, Hui-Guo Ding. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World Journal of Gastroenterology. 2011,17(41):4563-71.SCI
53. F.Ji,B.Yang,X.Peng,H.Ding,H.You,P.Tien*.Circulating microRNAs in hepatitisB virus–infected patients. Journal of Viral Hepatitis. 2011,01:443-450.SCI
54. 武彦宁*,蔡照华*,孙海梅,尚宏伟,郝刚,张立新,孙琳,张华,丁惠国*..非酒精性脂肪性肝炎大鼠肝脏内源性H2S合成减少. 首都医科大学学报. 2010,31(3):287-292.核心期刊
55. 李鹏,刘珲,孙琳,范春蕾,李磊,董培玲,张斌,李宁,丁惠国*..血清甲胎蛋白对原发性肝细胞癌的诊断价值再评价. 北京医学. 2010,32(9):712-715.核心期刊
56. 韩莹,孙琳,李鹏,刘晖,丁惠国*.肝组织CD8+、NK细胞浸润增加与慢性乙型肝炎恶化有关. 北京医学. 2010,32(9):703-707.核心期刊
57. DakeZhang*,SufangMa*,XinZhang*,HanqingZhao,HuiguoDing*,ChangqingZeng ..Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression. . BMC Infectious diseases. 2010,10:271-277.SCI
58. Hui Liu*, Peng Li*,Yun Zhai, Chun-Feng Qu,Li-Jie Zhang, Yu-Fen Tan, Ning Li, Hui-Guo Ding*. Diagnostic value of glypican-3 in sera and livers in primary hepatocellular carcinoma patients. . World Journal of Gastroenterology. 2010,16(35):4410-4415.SCI
59. Bing Li*,Bin Zhang*, Jun-Wei Ma, Peng Li, Lei Li, Yan-Ming Song, Hui-Guo Ding*. .High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases. . BMC Gastroenterology. 2010,10:54-58.SCI
60. 李鹏*,翟云,刘晖,吕福东,李宁,丁惠国*.血清AFP、GPC3、VEGF、IGF-Ⅱ单独及联合对原发性肝细胞癌的诊断价值. 世界华人消化杂志. 2010,18(25):2702-2706.核心期刊
61. Yun Zhai,Juan Zhang, Hong-wei Shang, Shi-chun Lu, Meng-long Wang, Hong You, Ji-Dong Jia and Hui guo Ding*.Octreotide decreases portal pressure: Hepatic stellatecells may play a pivotal role. African Journal of Biotechnology. 2010,9（12）:1833-1838.SCI
62. Fen Ji, Li Zhou,Sufang Ma, Feifei Li, Huiguo Ding,* and Changqing Zeng*.Dynamic Changes of HBV Quasispecies and Deletion Patterns in a Chronic Hepatitis B Patient. Journal of Medical Virology. 2009,81:1551–1559.SCI
63. 翟云, 蔡照华, 王利军, 丁惠国*.气体信号分子H2S在肝硬化门脉高压形成中的作用. 世界华人消化杂志 . 2009,17(26):2651-2653.
64. 勾春燕，阎海燕，尚宏伟，孙海梅，赵秀英，张立新，张华，江瑛,丁惠国＊.复方牛胎肝提取物减轻非酒精性脂肪性肝炎大鼠肝脏脂肪变性及炎症程度. 中华肝脏病杂志. 2009,17(2):141-142.
65. 李磊 平春霞 张斌 董培玲 阎海燕 丁惠国*.肝硬化门脉高压患者心脏泵功能减退. 中华肝脏病杂志. 2009,17(6):467-468.
66. 范春蕾 段瑾 董培玲 欧阳颖 张斌 平春霞 丁惠国*.肝硬化上消化道出血并发缺血性肝炎的临床特征与预后. 中华肝脏病杂志. 2009,17(4):258-262.
67. 丁惠国.长期控制肝硬化门脉高压症的策略. 中华肝脏病杂志. 2009,17(4):246-248.
68. 单 晶, 李玮芳, 李 鹏, 丁惠国*.慢性丙型肝炎非器官特异性自身抗体及其临床意义. 世界华人消化杂志. 2008,16(27) :3103-3105.
69. 王淑珍, 尚宏伟, 王兴翠, 李 冰, 张 斌, 丁惠国*.肝硬化患者Ghrelin、生长激素释放素的变化及其临床意义. . 世界华人消化杂志. 2008,16(28) :3230-3233.
70. 仇娇敏， 韩莹，计云霞，董培玲，尚宏伟，王兴翠，张斌，丁惠国*.HBV变异患者外周血CD4+CD25+调节性T细胞变化及其临床意义. 临床肝胆病杂志. 2008,24(6):419-422..
71. 尚宏伟 王利军 王兴翠 尤红 唐淑珍 高尔静 丁惠国* 贾继东.H2S对大鼠肝星状细胞内Ca2+浓度变化及细胞增殖的影响 . 解剖学报. 2008,39(6):103-106.
72. Peng DD,Han Y, Ding HG,WeiL*.Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. viral hepatology . 2008,23(5):1082-1088.SCI
73. N Li,L Zhou,P Dong B Zhang, R Xu,H Wang,H Ding*.Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. Digestive and liver. 2008,Marech:online.SCI
74. 吴光华，丁惠国,曾长青.公共核酸数据库HBV-DNA全序列概况和中国HBV参照序列的建立. 自然科学进展. 2008,18（2）:121-129.SCI
75. 汪得胜，丁惠国*,李卓,辛咏梅,张斌,李宁,陈德喜,殷继明.血清GPC3联合AFP对原发性肝癌的诊断价值探讨. 中华检验医学杂志. 2007,30(10):1169-1171.无
76. 王继荣,周莉,赵红斌,季芬,丁惠国,曾长青.北京地区乙型肝炎病毒S基因序列多态性及其分布. 世界华人消化杂志. 2007,15(23):3496-2502.无
77. 丁惠国.门静脉高压症内科治疗的选择与评价. 世界华人消化病杂志. 2007,15(14):1579-1582.无
78. Li ZHOU,Pei-lin DONG,Hui-guo DING*.Comparison scoring model of severe viral hepatitis and model for end stage liver disease for prediction the prognosis of patients with liver failure in China. world Journal of Gastroenterology. 2007,13(21):2999-3002.SCI
79. 卢实春,孟繁坤,丁惠国*,张劲光,丁蕾,王淑珍.不同剂量Octreotide对肝硬化门脉高压症断流术后患者血液动力学影响. 中华内科杂志. 2007,46(4):290-293.无
80. 张娟,丁惠国*,尤红,唐淑珍,尚宏伟,王兴翠,贾继东.SSTR亚型在人肝星状细胞表达及其临床意义. 首都医科大学学报. 2006,27(4):441-444.无
81. 范春蕾,吴燕京,丁惠国*,董培玲,张斌,周莉,平春霞,赵春惠.慢性重型肝炎能量代谢及糖、蛋白质及脂肪氧化临床研究. 中国临床营养杂志. 2006,14(2):110-114.无
82. 檀玉芬,董培玲,丁惠国*,张斌,范春蕾,贺红蕾,马军伟,赵春惠.终末期肝脏疾病患者内毒素增敏系统变化及临床意义. 中华消化杂志. 2006,26(6):417-418.无
83. 周莉,董培玲,丁惠国*,张仁敏,林伟,王慧芬,徐瑞平,王西钟,金瑞,赵春惠.rhGH联合乳果糖治疗慢性重型肝炎疗效分析. 中华急诊医学杂志. 2006,15(5):422-426.无
84. DING Hui-guo*,XIANG Hai-ping, SHAN Jing, ZHOU Li,MA Bin, LIU min, WANG Jun-tao.scoring modle for predicting the prognosis of severe viral hepatitis. Chinese Medical Journal. 2005,118(3):249-252.SCI
85. Hui-guo Ding*,Jing Shan,BinZhang, Hong-bo Ma,Li Zhou,Rui Jin, Yu-fen Tang, Li-xiang He.combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with chronic severe hepatitis B. world Journal Gastroenterology. 2005,17(11):2981-2983.SCI
86. 丁惠国*,尚宏伟,王兴翠,唐淑珍,孙异临,贾继东,赵春惠,王宝恩.复方861对HSC超微结构及细胞骨架蛋白的影响. 中华肝脏病杂志. 2005,13(6):553-554.无
87. 丁惠国*,王宝恩,赵春惠,贾继东,徐燕玲,唐淑珍.复方861对肝星状细胞L-VOCC表达的影响及临床意义. 中华肝脏病杂志. 2005,13(12):922-926.无
88. 单晶,徐瑞平,丁小君,王慧芬,林伟,马兵,董培玲,张斌,丁惠国*.重型肝炎患者预后模型临床应用分析. 中国危重病急救医学. 2005,17(10):586-588.无
89. DING Hui-guo*,Wang Bao-en,JIA Ji-dong, HARRY XIA Hua-xiang,BENJAMIN WONG Chun-yu, ZHAO Chun-hui, XU Yan-lin.Effects of octreotide on expression of L-VOCC and intracellular Ca2+ in activated hepatic stellate cells. Chinese Medical Journal. 2004,117(6):913-916.SCI
90. R cui*,J He, F Zhang, B Wang, HG Ding, H Shen, Y Li and X Chen.Diagnostic value of protein induced by vitamin K absence and GGT II as hepatocellular carcinoma markers complementary to AFP. British Juornal of Cancer. 2003,88(12):1878-1882.SCI
主编或副主编的著作/译著
1. 《不喂“痨”苦》,主编,中国协和医科大学出版社,20063
重要奖项
1. 肝硬化门脉高压症形成机制的基础与临床治疗研究 中国人民解放军医疗成果奖 二等 201110
2. 降低肝硬化上消化道出血病死率临床基础系列研究 中华科技奖 三等奖 201012
3. 降低肝硬化上消化道出血病死率临床基础系列研究 北京市科技进步奖 三等奖 200912
4. SARS基础与临床系列研究 国家科技进步奖 二等奖 2006
5. SARS临床与基础系列研究 北京市科技进步奖 一等奖 2005
6. 重型肝炎病理生理、预后及临床治疗研究 丰台区科技进步奖 一等奖 2005
7. 肝硬化门脉高压症药物治疗的细胞生物学基础 丰台区科技进步奖 三等奖 2005
8. SARS临床与基础系列研究 中华医学科技奖 二等奖 2004
9. 6676例各型病毒性肝炎内镜诊断与治疗临床研究 北京市科技进步奖 三等奖 2000